Appendix No. 12 - Number of cancer patients trial enrolled in prospective clinical cancer trials (in 201X) 1 2 3a 3b 3c 3d 3e 3f 3g 4 Disease site (without pediatric ICD-10 Number Number of % % IITs: PI**** % IITs: PI**** % Industry % % % tumors) according to the list Code of all cancer Columns Columns in Cancer Columns else-where columns Initiated columns Columns Columns Number of patients newly enrolled in trials in 201X Number of patients enrolled in trials in 201X of tumor localizations used in cancer patients Total Total Center 3b/Total 3a 3d/Total 3a Trials 3f/Total 3a Total 4/1 Total 4/2 the analysis of the Robert patients newly 3a/1 3a/2 Therapeutic Supportive 3a Screening/ Epidemiologic/ Prevention Biomarker TOTAL 4 Koch Institute ('Krebs in treated in diagnosed (Phase IV) Care (Sum 3a) Diagnostic/ Early Observational/ (Sum 4) Deutschland; 2013), modified the in 201X (Phase (Other) Detection Outcome on the basis of cancer the National Cancer center in Certification Program 2015 201X A. Head and Neck Stoma/Pharynx C00-14 Larynx C32 GI Tract Esophagus C15 Stomach C16 Intestine C18-21 Bladder Liver C22 Gall Bladder C23-24 Pancreas C25 Lung C33-34 Malignant Melanoma C43 Bone, Articular Cartilage, Connective and Soft Tissue C45-49 Breast/DCIS Ductal Carcinoma in Situ (DCIS) D05 Breast C50 C51 Cervix C53 Uterus C54-55 C56 Prostate C61 Testes C62 Kidney C64 Urinary Bladder C67 Central Nervous System Thyroid C73 Total Solid Tumors Morbus Hodgkin C81
Appendix No. 12 - Number of cancer patients enrolled in prospective clinical cancer trials (in 201X) 1 2 3a 3b 3c 3d 3e 3f 3g 4 Disease site (without pediatric tumors) according to the list of tumor localizations used in the analysis of the Robert Koch Institute ('Krebs in Deutschland; 2013), modified on the basis of the National Cancer Certification Program 2015 ICD-10 Code Number of all cancer patients treated in the cancer center in 201X Number of cancer patients newly diagnosed in 201X Number of patients newly enrolled in trials in 201X % Columns Total 3a/1 % Columns Total 3a/2 IITs: PI**** in Cancer Center % Columns 3b/Total 3a IITs: PI**** else-where % columns 3d/Total 3a Industry Initiated Trials % columns 3f/Total 3a Number of patients enrolled in trials in 201X % Columns Total 4/1 % Columns Total 4/2 (Phase Therapeutic (Phase IV) (Other) Supportive Care 3a (Sum 3a) Screening/ Diagnostic/ Early Detection Epidemiologic/ Observational/ Outcome Prevention Biomarker TOTAL 4 (Sum 4) A. Head and Neck Stoma/Pharynx C00-14 Larynx C32 GI Tract Esophagus C15 Stomach C16 Intestine C18-21 Bladder Liver C22 Gall Bladder C23-24 Pancreas C25 Lung C33-34 Malignant Melanoma C43 Bone, Articular Cartilage, Connective and Soft Tissue C45-49 Breast/DCIS Ductal Carcinoma in Situ (DCIS) D05 Breast C50 C51 Cervix C53 Uterus C54-55 C56 Prostate C61 Testes C62 Kidney C64 Urinary Bladder C67 Central Nervous System Thyroid C73 Total Solid Tumors Morbus Hodgkin C81 trial